Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance
Immune checkpoint blockade (ICB) therapy has improved long-term survival for patients with advanced melanoma. However, there is critical need to identify potential biomarkers of response and action...
biorxiv.org